ArticleJCO precision oncology2023
Erratum: Intracranial Activity of Selpercatinib in Chinese Patients With Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.